these modifications, and they can reversibly alter physiological states of cells. Particularly interesting is SUMOylation, a unique post-translational modification akin to ubiquitination, that conjugates small ubiquitin-like proteins called Small Ubiquitin-like MOdifier (SUMO) to target proteins and affects a number of processes, including the localization, degradation, binding, and activity of SUMOylated proteins. 6 Sentrin/SUMOspecific protease 2 (SENP2) is a de-SUMOylation enzyme that is important for both processing new SUMO proteins for conjugation as well as deconjugating SUMO from SUMOylated proteins. [7] [8] [9] Although 6 isoforms of SENPs exist in humans (SENP1-3 and 5-7), SENP2 specifically regulates p53 through Mdm2 de-SUMOylation, leading to apoptosis of cells. 10, 11 In ECs, we have found that SUMOylation plays an important role in regulating actin filament remodeling, 12 migration, 12 inflammation, 13 and apoptosis 5 that occur in response to flow stimulation. We have recently reported that disturbed flow activates protein kinase Cζ to induce p53 SUMOylation and subsequently increases endothelial apoptosis. 5 We have also reported that SUMOylation of extracellular signal-regulated kinase-5 (ERK5) inhibits ERK5-dependent activation of the anti-inflammatory molecule Krüppel-like factor 2 (KLF2), resulting in the loss of anti-inflammatory property of ERK5 that is normally activated by laminar shear stress. 13 Thus, it appears that SUMOylation of p53 and ERK5 plays a role in mediating endothelial inflammation and apoptosis. However, the role of SUMOylation, especially SENP2, in endothelial dysfunction and subsequent atherosclerosis remains unclear. We hypothesize that SENP2 regulates SUMOylation levels of p53 and ERK5 and may determine the healthy or diseased state of ECs, especially under the disturbed flow condition.
Methods
Detailed descriptions of the Materials and Methods are available in the Online Data Supplement. A brief description of the Methods used is given below.
Isolation of Mouse Aortic ECs and Lung ECs
Methods for isolation of mouse aortic ECs (MAECs) 14 or mouse lung ECs (MLECs) 15 were modified from published protocols.
ERK5 Transcriptional Activity Analysis
ERK5 transcriptional activity was assayed by the dual-luciferase reporter assay. 16 
Immunoprecipitation (SUMO Assay) and Western Blot Analysis
Immunoprecipitation and Western blotting analysis were performed as described previously. 17 
Real-Time Polymerase Chain Reaction Assay
Total RNA was extracted using the TRIzol reagent according to the manufacturer instructions, and reverse transcriptase reactions polymerase chain reaction were performed as described previously. 18 
Analysis of Apoptosis
Apoptosis was quantified by both terminal deoxy-ribonucleotide transferase-mediated dUTP nick-end labeling (TUNEL) staining and active caspase-3 expression, as described previously. 7
Mice
All animal procedures were performed with the approval from the University Committee on Animal Resources at the University of Rochester. Nontransgenic littermate control mice (Senp2 +/+ ; n=12) and SENP2 deficiency mice (Senp2 +/− ; n=12) or Senp2 +/+ /Ldlr −/− (n=25) and Senp2 +/− /Ldlr −/− (n=25; all female) in the C57BL/6J background were used.
En Face Immunostaining
The steady laminar flow and disturbed flow areas within the aorta were identified, and immunostaining was performed as described previously. 5
Leukocyte Rolling Assay and Vessel Diameter Measurements
Intravital microscopy was performed as previously described. 19 Briefly, the mesentery was externalized, and then rolling of rhodamine 6G labeled leukocytes in arterioles (≈20 µm in diameter) was recorded with a digital video camera.
Bone Marrow Transplantation
Bone marrow transplantation was performed as previously reported with minor modifications. 20 Briefly, female Ldlr −/− recipient mice at 6 weeks of age received a single semilethal dose of 900 rad irradiation using an RS2000 irradiator (Rad Source Technologies, Suwanee, GA). Bone marrow cells were harvested from Senp2 +/+ or Senp2 +/− nonirradiated donor mice, and 6×10 6 cells were injected via the postorbital vein into recipient mice immediately after irradiation.
Statistical Analysis
Data are presented as mean±SD. Statistical analyses by Wilcoxon signed-rank test, Kruskal-Wallis test, and Bonferroni multiple-comparison test were performed using the GraphPad Prism program, version 4.00 (GraphPad Software, Inc, CA) as described previously. 21
Results

SENP2 Inhibits Endothelial Apoptosis by Downregulating p53 SUMOylation
SUMOylation is a tightly regulated process within the cell, and proteins constantly undergo SUMOylation and de-SUMOylation, and SENPs are the enzymes primarily responsible for deconjugating SUMOylated proteins. It has recently been reported that cytosolic p53 directly interacts with B-cell lymphoma (Bcl-2) and loses its antiapoptotic stabilization effect on the outer mitochondrial membrane. 22, 23 We have also reported the crucial role of p53 SUMOylation on the interaction of Bcl-2 and p53 and subsequent disturbed flow-induced apoptosis in ECs. 7 Therefore, in this study, we
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ACh Acetylcholine Figure 1A and Online Figure  I ). Increased apoptosis in SENP depleted HAECs under both static and disturbed flow conditions, which were also detected by the expression of cleaved-caspase3 ( Figure 1B ). Next, we investigated the mechanism for this apoptosis by checking the role of SENP2 in regulating p53 SUMOylation. As suspected, knockdown of SENP2 increased p53 SUMOylation in HAECs ( Figure 1C ), MAECs (Online Figure IIA) , and HUVECs (Online Figure IIB ), whereas overexpression of adenoviral SENP2 (Ad-SENP2) ablated p53 SUMOylation ( Figure 1E ). In contrast to ECs stimulated with disturbed flow, those stimulated with steady laminar flow showed a decrease in p53 SUMOylation compared with those kept under the static condition ( Figure  1D ). Furthermore, in agreement with our previous report, 7 which showed the importance of p53 SUMOylation state on the interaction between Bcl-2 and p53, depletion of SENP2 increased Bcl-2-p53 interaction ( Figure 1F ).
To determine the involvement of p53 SUMOylation in the reduction of SENP2-mediated endothelial apoptosis, we isolated MLECs from the heterozygous Senp2 +/− and littermate wild-type (WT) Senp2 +/+ mice and determined constitutive levels of p53 SUMOylation. We found significantly increased p53 SUMOylation in the MLECs from Senp2 +/− mice compared with those from Senp2 +/+ (Figure 2A ). p53 SUMOylation was also increased in MAECs isolated from Senp2 +/− mice compared with those isolated from control Senp2 +/+ mice ( Figure  2B ; 1st versus 3rd lane). However, the enhancement of p53 SUMOylation induced by disturbed flow in Senp +/− MAECs compared with control Senp +/+ cells was marginal ( Figure  2B , 2nd versus 4th lane). The reason for this is not clear, but it is possible that p53 SUMOylation may be at the maximum level in MAECs isolated from Senp2 +/− mice, so that disturbed flow cannot further augment the p53 SUMOylation level in these cells. However, when we examined the p53 and ERK5 SUMOylation in HAECs ( Figures 1C and 3C ), MAECs (Online Figure IIA) , and HUVECs (Online Figure IIB and IIC) using a siRNA of SENP2 in vitro, we found synergic effect of disturbed flow on the p53/ERK5 SUMOylation by SENP2 depletion. Because the disturbed flow decreased de-SUMOylation activity of SENP2 against p53 and ERK5, the depletion of SENP2 study itself has its own limitation to prove the role of SENP2 on p53 and ERK5 SUMOylation under disturbed flow.
Next, we determine the effect of p53 SUMOylation on EC apoptosis using adenoviruses containing WT p53 (Ad-p53-WT) and the SUMOylation site mutant p53-K386R (Ad-p53-K386R). A significant increase in apoptosis was noted in ECs from Senp2 +/− mice compared with those from Senp2 +/+ transduced by Ad-LacZ control, confirming the data obtained using HUVECs ( Figure 2C ). Increased apoptosis in Senp2 +/− MLECs was also detected by the expression of cleaved-caspase3 ( Figure  4F ). We then transduced Ad-p53-WT or Ad-p53-K368R mutant in MLECs isolated from Senp2 +/− and found that the p53 SUMOylation mutant significantly inhibited apoptosis ( Figure   2C ), demonstrating the importance of SENP2 in regulating p53 SUMOylation-mediated ECs apoptosis.
SENP2 Inhibits Disturbed Flow-Mediated Endothelial ERK5 SUMOylation
Previously, we have reported that reactive oxygen species or advanced glycation end products induce ERK5 SUMOylation, inhibiting its transactivation function and subsequently decreasing expression of KLF2 and endothelial NO synthase (eNOS). 13 However, it is not known whether disturbed flow regulates ERK5 SUMOylation or whether it is involved in EC inflammation. First, we examined whether disturbed flow could increase ERK5 SUMOylation and found that it significantly heightened ERK5 SUMOylation ( Figure  3A ). In contrast, steady laminar flow downregulated ERK5 SUMOylation 24 ( Figure 3B ). Second, to investigate the involvement of endogenous SENP2 on disturbed flow-induced ERK5 SUMOylation, we depleted SENP2 expression by siRNA in both HAECs and HUVECs and found that SENP2 depletion increased the baseline level of ERK5 SUMOylation (3rd lane) and disturbed flow-induced ERK5 SUMOylation was significantly amplified (4th lane) in both cell types ( Figure  3C and Online Figure IIC) . We also performed a gain-of-function study and found that overexpression of SENP2 completely abolished the disturbed flow effect on ERK5 SUMOylation ( Figure 3D ), suggesting a critical role of SENP2 in disturbed flow-induced ERK5 SUMOylation.
ERK5 Transactivation and Expression of eNOS and KLF2 Are Inhibited, Whereas Adhesion Molecule Expression Is Increased by Disturbed Flow in a SENP2-Dependent Manner
Because ERK5 SUMOylation by disturbed flow decreased ERK5 transcriptional activity and consequent expression of KLF2 and eNOS, 13 we first determined the effects of depletion and overexpression of SENP2 on ERK5 transcriptional activity. Disturbed flow decreased ERK5 transcriptional activity, which was further decreased by SENP2 siRNA, whereas Ad-SENP2 transduction reversed it ( Figure 3E ). Next, we investigated the KLF2 and eNOS expression and found that their expression was decreased by disturbed flow ( Figure 3F ). SENP2 deficiency inhibited their expression under the static condition, but it did so more strongly under the disturbed flow condition ( Figure 3F ). In contrast, when SENP2 was overexpressed, the expression of KLF2 and eNOS increased, and the disturbed flow effect was abolished ( Figure 3G ). KLF2 antagonizes inflammatory gene expression. 13 Therefore, we also examined adhesion molecule expression induced by disturbed flow. Disturbed flow increased the expression of E-selectin, intercellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1, which was significantly enhanced by the depletion of SENP2 ( Figure 3H ), whereas its overexpression had the opposite effect ( Figure 3I ). These data suggest a crucial role of SENP2 in regulating ECs inflammation.
Inhibition of KLF2 and eNOS and Upregulated Adhesion Molecule Expression in MLECs From Senp2 +/− Mice
MLECs and MAECs were isolated from Senp2 +/− and Senp2 +/+ mice, and ERK5 SUMOylation levels were examined. ERK5 SUMOylation was significantly higher in Senp2 +/− MLECs compared with Senp2 +/+ MLECs ( Figure 4A ). Of note, compared with HUVECs, MLECs and MAECs expressed a greater level of the lower molecular weight ERK5 isoform at around 75 kDa as we previously reported. 25 The same results were obtained in the Senp2 +/− versus Senp2 +/+ MAEC comparison ( Figure 4B ). However, the enhancement of ERK5 SUMOylation by disturbed flow in Senp +/− cells was also marginal as we have shown in p53 SUMOylation in Figure  2B . ERK5 transcriptional activity and the KLF2 and eNOS mRNA expression were decreased in Senp2 +/− MLECs ( Figure  4C and 4D).
Because KLF2 has an anti-inflammatory effect in ECs, 13, 26 we examined the role of SENP2 in cytokine-mediated EC inflammation. Increased expression of ICAM-1 and VCAM-1 mRNAs was noted in Senp2 +/− MLECs compared with Senp2 +/+ MLECs ( Figure 4E ). The expression of E-selectin, ICAM-1, and VCAM-1 mRNAs was induced by tumor necrosis factors (TNF)α stimulation in Senp2 +/+ MLECs, which was further increased in Senp2 +/− MLECs. We also found increased expression of E-selectin, ICAM-1, and VCAM-1 proteins in Senp2 +/− MLECs ( Figure 4F ). It is possible that increased ERK5 SUMOylation under the inflammatory condition is because of reduced SENP2 expression in ECs. 
ERK5 SUMOylation Inhibits KLF2 and eNOS and Upregulates Adhesion Molecule Expression in Senp2 +/− ECs
To determine the effects of ERK5 SUMOylation on SENP2mediated anti-inflammatory events in ECs, we transduced adenoviruses containing ERK5 WT (Ad-ERK5-WT) and ERK5 SUMOylation site mutant (Ad-ERK5-K6/22R) in Senp2 +/− cells. Increased expression of E-selectin, VCAM-1, and ICAM-1 mRNA in Senp2 +/− MLECs was partially downregulated in cells transduced by Ad-ERK5-WT, but their expression was completely inhibited in Senp2 +/− MLECs transduced by the Ad-ERK5-K6/22R mutant ( Figure 5A ). Furthermore, reduced expression of eNOS and KLF2 mRNAs in Senp2 +/− MLECs was blunted by Ad-ERK5-WT, but Ad-ERK5-K6/22R mutant transduction strongly upregulated their mRNA levels ( Figure 5B ). We confirmed similar expression levels of Figure 4 . Disturbed flow inhibits ERK5 transcriptional activity and the expression of endothelial NO synthase (eNOS) and Kruppellike factor 2 (KLF2) and increases adhesion molecule expression via sentrin/Small Ubiquitin-like MOdifier (SUMO)-specific protease 2 (SENP2). A, ERK5 SUMOylation was studied in mouse lung endothelial cells (MLECs) isolated from 3 different Senp2 +/+ or Senp2 +/− mice using immunoprecipitation with rabbit anti-ERK5 followed by Western blotting with mouse anti-SUMO2/3 (top). SENP2, p53, or SUMO expression was detected by specific antibodies as indicated. B, ERK5 SUMOylation was observed in mouse aortic ECs (MAECs) isolated from Senp2 +/+ or Senp2 +/− mice with or without disturbed flow for 3 hours using immunoprecipitation with rabbit anti-p53 followed by Western blotting with mouse anti-SUMO2/3 (top). Antibodies specific to SENP2, p53, or SUMO2/3 were used to detect the expression level of each protein. p53 SUMOylation was quantified as described in Materials and Methods (bottom). Shown is mean±SD, (n=3). *P<0.05, **P<0.01. C, ERK5 transcriptional activity was examined as described in Figure 3E in MLECs from Senp2 +/+ and Senp2 +/− mice. Shown is the mean±SD, (n=3). **P<0.01. D, mRNA levels of eNOS and KLF2 were determined by quantitative real-time polymerase chain reaction (qRT-PCR) as described in methods. Shown is the mean±SD (n=3). **P<0.01. E, mRNA levels of adhesion molecules in Senp2 +/+ or Senp2 +/− MLECs treated with vehicle or tumor necrosis factors α for 6 hours were assessed by qRT-PCR as described in the methods. Results were expressed as relative fold-increases vs vehicle-treated Senp2 +/+ cells. Shown is the mean±SD (n=3). *P<0.05, **P<0.01. F, Expressions of eNOS, adhesion molecules as well as cleaved-caspase3 in MLECs isolated from 3 different Senp2 +/+ or Senp2 +/− mice were determined by Western blotting. Platelet endothelial cell adhesion molecule-1 expression was used to show the identity of cells as ECs. casp.3 indicates caspase-3; d-flow, disturbed flow; IB, immunoblotting; IP, immunoprecipitation. and Veh, vehicle. March 15, 2013 ERK5-WT and ERK5-K6/22R mutant in MLECs ( Figure 5C ). E-selectin, VCAM-1, and ICAM-1 protein expression levels were significantly decreased in Senp2 +/− MLECs transduced by Ad-ERK5-K6/22R mutant compared with those in Ad-LacZ or Ad-ERK5-WT transduced Senp2 +/− MLECs ( Figure  5D ). These data suggest a crucial role of ERK5 SUMOylation in the SENP2-mediated downregulation of EC inflammation.
To determine the role of ERK5 SUMOylation in apoptosis induced by disturbed flow, we transduced Ad-ERK5-WT and Ad-ERK5-K6/22R in MAECs from Senp2 +/+ mice. Both Ad-ERK5-WT and Ad-ERK5-K6/22R reduced the disturbed flow-induced TUNEL staining and cleaved-caspase3 expression ( Figure 5E-5G ), suggesting that ERK5 indeed inhibits apoptosis as we have previously reported 27 but that ERK5 SUMOylation is not involved in this process. Because we have reported that SUMOylation does not affect ERK5 kinase activity, 24 we assume that another ERK5 kinase substrate, such as serum and glucocorticoid-induced protein kinase, 28 may be involved in this process.
En Face Immunohistochemistry for Apoptosis, E-Selectin, and VCAM-1 in the Aorta of Senp2 +/+ and Senp2 +/− Mice
We investigated whether reduced SENP2 expression affected EC apoptosis in vivo. En face preparations of aortas of 7-week-old Senp2 +/+ mice were coimmunostained for TUNEL and VE-cadherin (red; Figure 6A ) or AnnexinV (red) and VEcadherin (green; Figure 6B ). For imaging, we focused on areas exposed to either disturbed flow (lesser curvature of aortic arch) or steady laminar flow (greater curvature of aortic arch) as described previously 29 (see Methods). Whereas the TUNEL and annexinV positive cells were rare in the steady laminar flow area, they were frequently detected in the disturbed flow area in Senp2 +/+ mice ( Figure 6A and 6B) . Interestingly, we found increased numbers of TUNEL and annexinV positive cells in both disturbed and steady laminar flow areas in the Senp2 +/− mice ( Figure 6A and 6B) , confirming a critical role of SENP2 in disturbed flow-mediated apoptosis in vivo.
Because the increased expression of E-selectin and VCAM-1 in disturbed flow areas has been reported, we investigated their expression in the Senp2 +/+ and Senp2 +/− mice (Figure 6D  and 6E ). Staining by both anti-E-selectin and anti-VCAM-1 was significantly stronger in disturbed flow areas than in steady laminar flow areas in Senp2 +/+ mice. We found that the expression of E-selectin and VCAM-1 was markedly increased in the steady laminar flow area of Senp2 +/− mice compared with Senp2 +/+ mice (Figure 6D-6F) . Nonimmune control immunoglobulin G yielded no visual fluorescence in Figure 5 . The crucial role of ERK5 SUMOylation in inflammation and apoptosis in mouse lung endothelial cells (MLECs) and mouse aortic ECs (MAECs). A and B, MLECs isolated from 3 different Senp2 +/− mice were transduced with indicated Ad for 18 hours, and mRNA levels were determined by qRT-PCR using indicated specific primers as described in Figure 3H . Shown is the mean±SD (n=3). *P<0.05, **P<0.01. C, ERK5-WT and ERK5-K6/22R expression were confirmed by Western blotting. D, MLECs isolated from 3 different Senp2 +/− mice were transduced with indicated Ad for 18 hours, and expressions of adhesion molecules were determined by Western blotting with indicated antibodies. both disturbed and steady laminar flow areas (Online Figure  III) . These data suggest a critical role of SENP2 in regulating the endothelial E-selectin and VCAM-1 expression in vivo.
ECs Dysfunction in Senp2 +/− Mice
We investigated leukocyte rolling in and acetylcholine (ACh)-induced dilation of mesenteric arterioles of Senp2 +/− and Senp2 +/+ mice. Increased leukocyte rolling was observed in Senp2 +/− compared with Senp2 +/+ mice ( Figure  7A -7C and Online Movies I and II). No differences were found in vessel diameter or shear rate between these animals (data not shown). ACh-induced arteriole dilatation was decreased in Senp2 +/− mice (Figure 7C; left) . However, EC-independent vasodilation by sodium nitroprusside was indistinguishable between the 2 mice ( Figure 7C; right) . We also investigated effects of L-NG-Nitroarginine Methyl Ester in both Senp2 +/+ and Senp2 +/− mice on vessel responses to ACh and found that L-NG-Nitroarginine Methyl Ester pretreatment abolished vasodilatation by ACh, but not sodium nitroprusside, in both Senp2 +/− and Senp2 +/+ mice, suggesting that ACh-mediated vasodilatation was attributable to NO production ( Figure 7D ).
Reduced SENP2 Expression Elevates Atherosclerotic Plaque Formation, Which Is Mediated by Vascular but Not by Hematopoietic Cells
To examine the role of SENP2 in atherosclerosis formation, we generated a double-knock out Senp2 +/− /Ldlr −/− mouse model and compared the extent of atherosclerosis formation in these mice with that in Senp2 +/+ /Ldlr −/− mice after 16 weeks on a high-cholesterol diet. The lesion area in both aortic arch and descending aorta was significantly larger in Senp2 +/− /Ldlr −/− than in Senp2 +/+ /Ldlr −/− mice ( Figure 8A ; top 2 panels). We also found that the lesion size observed in histological sections of the aortic valve region was larger in Senp2 +/− /Ldlr −/− than in Senp2 +/+ /Ldlr −/− mice ( Figure 8A; bottom 2 panels) . Interestingly, the extent of increase in the lesion size in the aortic arch of Senp2 +/− /Ldlr −/− mice was much larger than that in descending aorta ( Figure 8A ; top 2 panels). It is well known that the lesser curvature area of the aortic arch is subjected to disturbed flow. 30 Therefore, the significant lesion size expansion in this area in Senp2 +/− /Ldlr −/− mice suggests the crucial role of disturbed flow-induced SUMOylation of proteins, including p53 and ERK5 on atherosclerosis formation. No differences were noted in their body weight and blood contents of total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol (Online Figure IV) . To investigate whether the increased atherosclerotic formation in Senp2 +/− /Ldlr −/− mice was attributable to SENP2 reduction in vessel cells (ECs) or hematopoietic cells, we performed bone marrow transplantation. Bone marrow cells from Senp2 +/+ or Senp2 +/− mice were transplanted into 6-week-old semilethally irradiated Ldlr −/− mice. After 6 weeks of recovery, the mice were given a high-cholesterol diet for 12 additional weeks ( Figure 8B ). Successful chimerism of bone marrow cells was confirmed by Western blotting against total lysates of blood cells isolated from recipient mice ( Figure 8C; right, bottom) . Ldlr −/− mice that received Senp2 +/− hematopoietic cells showed the same extent of vascular lesion development in the aortic root as the mice given cells from Senp2 +/+ donors ( Figure 8C ), suggesting that vascular SENP2 expression regulates atherosclerosis formation.
Discussion
Disturbed flow induces a proinflammatory state in ECs that counters the beneficial effects of laminar shear stress. 4 The loss of this protective signaling makes the endothelium vulnerable to becoming dysfunctional and subsequently to developing atherosclerosis. Post-translational modifications of proteins have emerged as important regulators of signaling attributable to the vast array of reversible changes they can induce in both physiological and pathological pathways. SUMOylation is one of the most dynamic post-translational modifications with its diverse repertoire of effects ranging from protein localization to transcriptional regulation and DNA binding. 6, 31 In this study, we found that disturbed flow induced SUMOylation of p53 and ERK5, leading to EC apoptosis and inflammation, respectively ( Figure 8D ). We found that reduced expression of SENP2 increased both p53 and ERK5 SUMOylation, hence increased EC dysfunction and inflammation, and accelerated atherosclerosis formation in vivo. We also found that in mice (1) reduced expression of SENP2 in hematopoietic cells did not affect atherosclerosis formation, (2) ACh-but not sodium nitroprusside-induced vasodilation was dampened by reduced SENP2, and (3) reduced SENP2 levels increased apoptosis and E-selectin and VCAM-1 expression in vivo. These results indicate for the first time that SENP2 function plays an important role in atherosclerosis formation, at least in mice. We caution here that ERK5 and p53 are most likely not the only proteins whose SUMOylation levels are increased by SENP2 depletion, and it is possible that other SUMOylatable molecules may be involved in the increased vascular events in Senp2 +/− /Ldlr −/− mice. However, because the disturbed flow-induced adhesion molecule expression and EC apoptosis were inhibited by a p53 or ERK5 SUMOylation mutant, we may tentatively conclude that SUMOylation of p53 and ERK5 has significant effects on disturbed flow-induced endothelial apoptosis and inflammation, respectively ( Figure 8D ). To our knowledge this is the first report that describes an important role of SENP2 in disturbed flow-induced EC dysfunction and inflammation. Because we did not find a decrease in SENP2 expression under the disturbed flow condition, it is possible that disturbed flow inhibits its activity or changes its cellular localization, which may involve some post-translational modifications. In fact, it has been reported that SENP2 contains both a bipartite nuclear localization signal and a chromosome region maintenance 1-dependent nuclear export signal and that its function can be regulated by nucleo-cytoplasmic shuttling. 32 Attributable partly to the lack of appropriate antibodies for immunostaining, SENP2 cellular localization was not studied at this time. We will focus on this issue in our next study.
In this study, we have reported the involvement of SENP2 on endothelial inflammation. It was reported that in mouse embryonic fibroblasts, SENP2 efficiently associated with nuclear factor-kappa B (NF-κB) essential modulator, de-SUMOylated NF-κB essential modulator, inhibited NF-κB activation, and accelerated cell death induced by DNA damage. 33 However, Senp2 −/− mouse embryonic fibroblasts were not resistant to cell death induced by TNFα (+ cyclohexomide). 33 In our current study, we found that TNFα induced a significant increase in adhesion molecule expression in Senp2 +/− ECs. Thus, the regulatory mechanism of SENP2 on TNFα-mediated signaling might be different between ECs and mouse embryonic fibroblasts. It is possible that NF-κB essential modulator SUMOylation in Senp2 +/− ECs is also involved in EC inflammation, but we found that the ERK5 SUMOylation mutant significantly inhibited adhesion molecule induction in Senp2 +/− ECs. This suggests a crucial role of ERK5 SUMOylation in regulating EC inflammation. The possible interplay between NF-κB essential modulator and ERK5 on regulating NF-κB signaling needs to be studied further.
An expanded Results and Discussion section is available in the Online Data Supplement.
What Is Known?
• Disturbed flow in branches and bifurcations of the arterial tree promotes atherogenesis via endothelial cell apoptosis and inflammation. • Sentrin/Small Ubiquitin-like Modifier (SUMO)-specific protease 2 (SENP2) catalyzes de-SUMOylation of proteins and thereby regulates localization, degradation, binding, and activity of SUMOylated proteins. • Disturbed flow activates protein kinase Cζ -induced p53 SUMOylation and p53 binding to Bcl-2 in the cytoplasm, leading to endothelial cell (EC) apoptosis.
• SUMOylation of ERK5 inhibits laminar flow-induced expression of
Kruppel-like factor 2, which is a key anti-inflammatory transcription factor, resulting in the loss of the anti-inflammatory effects of ERK5.
What New Information Does This Article Contribute?
• Both p53 and ERK5 were SUMOylated in response to disturbed, but not laminar, flow. • Deletion of SENP2 enhanced disturbed flow-induced EC apoptosis and inflammation by upregulating p53 and ERK5 SUMOylation, respectively. • EC apoptosis, adhesion molecules expression, and atherogenesis were increased in both disturbed flow and steady laminar flow areas in Senp2 +/− or Senp2 +/− /Ldlr −/− mice aorta.
• The lesion size in the aortic arch of Senp2 +/− /Ldlr −/− mice was much larger than that in descending aorta.
Several studies demonstrate that disturbed flow is proatherogenic.
Here, we show that SENP2 plays a unique role in disturbed flowinduced EC apoptosis and inflammation via regulating p53 and ERK5 SUMOylation, respectively. We found that deletion of SENP2 enhanced disturbed flow-induced EC apoptosis and E-selectin and VCAM-1 expression, and subsequent atherosclerotic lesion formation. Notably, the lesion size in the aortic arch of Senp2deficient mice, where ECs are mainly exposed by disturbed flow, was much larger than that in the descending aorta, suggesting the crucial role of SENP2 on atherogenesis under disturbed flow. Ldlr −/− mice that received Senp2 +/− hematopoietic cells showed the same extent of atherosclerotic lesion formation as the mice given cells from Senp2 +/− hematopoietic cells from Senp2 +/+ donors, demonstrating the crucial role of vascular cell SENP2 on regulating atherogenesis. These findings reveal a novel pathway of SENP2-mediated SUMOylation of p53 and ERK5, which leads to EC dysfunction and increased atherogenesis especially under the disturbed flow.
Novelty and Significance
